Toll-like receptors and control of mycobacterial infection in mice

Novartis Foundation Symposium

Volumn 279, Issue , 2006, Pages 127-139

  Ryffel, Bernhard ^a,b   Jacobs, Muazzam ^b   Parida, Shreemanta ^c   Botha, Tania ^d   Togbe, Dieudonnée ^a   Quesniaux, Valerie ^a  

^a CNRS   (France)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^d CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR;

ANIMAL; IMMUNOLOGY; MICROBIOLOGY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; LIGANDS; MICE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33847751114     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (83)

1. Abel B, Thieblemont N, Quesniaux VJ et al 2002 Toll-like receptor 4 expression is required to control chronic mycobacterium tuberculosis infection in mice. J Immunol 169:3155-3162
2. Akira S, Takeda K 2004 Toll-like receptor signalling. Nat Rev Immunol 4:499-511
3. Akira S, Yamamoto M, Takeda K 2003 Role of adapters in toll-like receptor signalling. Biochem Soc Trans 31:637-642
4. Aliprantis AO, Yang RB, Mark MR et al 1999 Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736-739
5. Barnes PF, Chatterjee D, Abrams JS et al 1992 Cytokine production induced by mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol 149:541-547
6. Botha T, Ryffel B 2003 Reactivation of latent tuberculosis infection in TNF-deficient mice. J Immunol 171:3110-3118
7. Branger J, Leemans JC, Florquin S et al 2004 Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int Immunol 16:509-516
8. Brightbill HD, Libraty DH, Krutzik SR et al 1999 Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-736
9. Bulut Y, Faure E, Thomas L, Equils O, Arditi M 2001 Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 167:987-994
10. Chamaillard M, Hashimoto M, Horie Y et al 2003 An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4:702-707
11. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR 1995 Effects of nitric oxide synthase inhibitors on murine infection with mycobacterium tuberculosis. Infect Immun 63:736-740
12. Chatterjee D, Khoo KH 1998 Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8:113-120
13. Cooper AM, Kipnis A, Turner J et al 2002 Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 168:1322-1327
14. Daffe M, Draper P 1998 The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39:131-203
15. Drennan MB, Nicolle D, Quesniaux VJ et al 2004 Toll-like receptor 2-deficient mice succumb to mycobacterium tuberculosis infection. Am J Pathol 164:49-57
16. Ehlers S, Holscher C, Scheu S et al 2003 The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and listeria monocytogenes. J Immunol 170:5210-5218
17. Ehrt S, Schnappinger D, Bekiranov S et al 2001 Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194:1123-1140
18. Flynn JL 2004 Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 84:93-101
19. Flynn JL, Chan J 2001a Immunology of tuberculosis. Annu Rev Immunol 19:93-129
20. Flynn JL, Chan J 2001b Tuberculosis: latency and reactivation. Infect Immun 69:4195-4201
21. Flynn JL, Chan J 2003 Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 15:450-455
22. Flynn JL, Goldstein MM, Chan J et al 1995 Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572
23. Flynn JL, Scanga CA, Tanaka KE, Chan J 1998 Effects of aminoguanidine on latent murine tuberculosis. J Immunol 160:1796-803
24. Fremond CM, Nicolle DM, Torres DS, Quesniaux VF 2003 Control of Mycobacterium bovis BCG infection with increased inflammation in TLR4-deficient mice. Microbes Infect 5:1070-1081
25. Fremond C, Yeremeev V, Nicolle D et al 2004 Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest 114:1790-1799
26. Garcia I, Guler R, Vesin D et al 2000 Lethal Mycobacterium bovis Bacillus Calmette Guerin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest 80:1385-1397
27. Gehring AJ, Rojas RE, Canaday DH et al 2003 The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun 71:4487-4497
28. Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH 2004 Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol 173:2660-2668
29. Gilleron M, Quesniaux VF, Puzo G 2003 Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem 278:29880-29889
30. Girardin SE, Boneca IG, Carneiro LA et al 2003a Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-1587
31. Girardin SE, Hugot JP, Sansonetti PJ 2003b Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 24:652-658
32. Gomes MS, Florido M, Pais TF, Appelberg R 1999 Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J Immunol 162:6734-6739
33. Gomez JE, McKinney JD 2004 M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 84:29-44
34. Greenstein RJ 2003 Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 3:507-514
35. Hajjar AM, O'Mahony DS, Ozinsky A et al 2001 Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166:15-19
36. Heldwein KA, Liang MD, Andresen TK et al 2003 TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J Leukoc Biol 74:277-286
37. Hoebe K, Du X, Georgel P et al 2003 Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748
38. Holscher C, Atkinson RA, Arendse B et al 2001 A protective and agonistic function of IL-12p40 in Mycobacterial infection. J Immunol 167:6957-6966
39. Horng T, Barton GM, Flavell RA, Medzhitov R 2002 The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329-333
40. Inohara N, Nunez G 2003 NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3:371-382
41. Jacobs M, Brown N, Allie N, Ryffel B 2000a Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin Immunol 94:192-199
42. Jacobs M, Marino MW, Brown N et al 2000b Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation. Lab Invest 80:901-914
43. Janeway CA Jr, Medzhitov R 2002 Innate immune recognition. Annu Rev Immunol 20:197-216
44. Jones BW, Heldwein KA, Means TK, Saukkonen JJ, Fenton MJ 2001a Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis 60 Suppl 3:iii6-12
45. Jones BW, Means TK, Heldwein KA et al 2001b Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 69:1036-1044
46. Kamath AB, Alt J, Debbabi H, Behar SM 2003 Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis. Infect Immun 71:4112-4118
47. Lazarevic V, Myers AJ, Scanga CA, Flynn JL 2003 CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19:823-835
48. Means TK, Lien E, Yoshimura A et al 1999a The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 163:6748-6755
49. Means TK, Wang S, Lien E et al 1999b Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163:3920-3927
50. Means TK, Jones BW, Schromm AB et al 2001 Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 166:4074-4082
51. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr 1997 A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397
52. Mohan VP, Scanga CA, Yu K et al 2001 Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69:1847-1855
53. Nicolle DM, Pichon X, Bouchot A et al 2004a Chronic pneumonia despite adaptive immune response to Mycobacterium bovis BCG in MyD88-deficient mice. Lab Invest 84:1305-1321
54. Nicolle DM, Fremond C, Pichon X et al 2004b Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-Like receptors: investigation on TLR2, TLR6 or TLR2-TLR4 deficient mice. Infect Immun 72:6994-7004
55. Nigou J, Gilleron M, Rojas M et al 2002 Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response. Microbes Infect 4:945-953
56. North RJ, Jung YJ 2004 Immunity to tuberculosis. Annu Rev Immunol 22:599-623
57. Noss EH, Harding CV, Boom WH 2000 Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol 201:63-74
58. Noss EH, Pai RK, Sellati TJ et al 2001 Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 167:910-918
59. O'Neill LA, Fitzgerald KA, Bowie AG 2003 The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 24:286-289
60. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T 2003 TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4:161-167
61. Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV 2003 Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol 171:175-184
62. Quesniaux V, Ryffel B 2004 Toll-like receptors: emerging targets of immunomodulation. Expert Opin Ther Patents 14:85-100
63. Quesniaux V, Fremond C, Jacobs M et al 2004a Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect 6:946-959
64. Quesniaux VJ, Nicolle DM, Torres D et al 2004b Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 172:4425-4434
65. Reed MB, Domenech P, Manca C et al 2004 A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431:84-87
66. Reiling N, Holscher C, Fehrenbach A et al 2002 Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 169:3480-3484
67. Roach DR, Briscoe H, Baumgart K, Rathjen DA, Britton WJ 1999 Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect Immun 67:5473-5476
68. Roach DR, Briscoe H, Saunders B et al 2001 Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 193:239-246
69. Ryffel B, Fremond C, Jacobs M et al 2005 Innate immunity to mycobacterial infection in mice: critical role for Toll-like receptors. Tuberculosis (Edinb) 85:395-405
70. Scanga CA, Mohan VP, Joseph H et al 1999 Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun 67:4531-4538
71. Scanga CA, Mohan VP, Yu K et al 2000 Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med 192:347-358
72. Scanga CA, Bafica A, Feng CG et al 2004 MyD88-deficient mice display a profound loss in resistance to mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun 72:2400-2404
73. Shi S, Nathan C, Schnappinger D et al 2003 MyD88 primes macrophages for full-scale activation by interferon-γ yet mediates few responses to Mycobacterium tuberculosis. J Exp Med 198:987-997
74. Shim TS, Turner OC, Orme IM 2003 Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 83:367-371
75. Sugawara I, Yamada H, Li C et al 2003 Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol 47:327-336
76. Takeda K, Akira S 2004 TLR signaling pathways. Semin Immunol 16:3-9
77. Underhill DM 2003 Mini-review Toll-like receptors: networking for success. Eur J Immunol 33:1767-1775
78. Underhill DM, Bassetti M, Rudensky A, Aderem A 1999 Dynamic interactions of macrophages with T cells during antigen presentation. J Exp Med 190:1909-1914
79. Vignal C, Guerardel Y, Kremer L et al 2003 Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. J Immunol 171:2014-2023
80. Yamamoto M, Sato S, Hemmi H et al 2002a Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420:324-329
81. Yamamoto M, Sato S, Mori K et al 2002b Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169:6668-6672
82. Yamamoto M, Sato S, Hemmi H et al 2003 Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640-643
83. Zhang D, Zhang G, Hayden MS et al 2004 A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-1126